Linda Rhodes, VMD, PhD
Animal Health Entrepreneur & Veterinarian
Linda began her career as a large animal practitioner before joining the R&D group at Merck and later leading clinical research at Merial. In 2001 she co-found AlcheraBio, a CRO specializing in helping clients develop new drugs for animals. In 2011, Dr. Rhodes became the founding CEO of Aratana Therapeutics, a company that developed dog and cat therapeutics, and subsequently, when the company went public, she served as its Chief Scientific Officer. After retiring from Aratana in 2016, Dr. Rhodes was appointed to the Board of Directors of Zoetis. She received her BA from Sarah Lawrence College, her VMD from the University of Pennsylvania, and her PhD from Cornell University.